ANKE BIO(SZ:300009) Xin Lang Cai Jing·2025-08-22 01:26Group 1 - Anke Bio (300009.SZ) released its semi-annual report for 2025 on August 22, 2025, showing that as of August 21, 2025, 12 institutional investors held a total of 81.64 million shares, accounting for 4.88% of the total share capital [1] - The top ten institutional investors include Hong Kong Central Clearing Limited, Bank of China - CMB National Bio-Medicine Index Fund, Shanghai Bank - Yinhua CSI Innovative Drug Industry ETF, and others, with a combined holding ratio of 4.88%, which decreased by 0.62 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, three funds reduced their holdings compared to the previous quarter, including the Innovative Drug Fund and CMB National Bio-Medicine Index A, with a reduction ratio of 0.31% [2] - Seven new public funds were disclosed this period, including Southern CSI 1000 ETF and various funds from Fortune, while two funds were no longer disclosed compared to the previous quarter [2] - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 0.44% compared to the previous period [2]